Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
IPN-60250 by Ipsen for Liver Diseases: Likelihood of Approval
IPN-60250 is under clinical development by Ipsen and currently in Phase I for Liver Diseases. According to GlobalData, Phase I...
Data Insights
IPN-60250 by Ipsen for Primary Biliary Cholangitis (Primary Biliary Cirrhosis): Likelihood of Approval
IPN-60250 is under clinical development by Ipsen and currently in Phase I for Primary Biliary Cholangitis (Primary Biliary Cirrhosis). According...